Skip to content

ALKS

Alkermes plc

NASDAQ · IEHealthcareBiotechnology
$51.72-1.90%

Price as of Jul 20, 2026

ALKS capital

Alkermes plc capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.90x
Net debt / equity
0.70x
Debt / assets
0.37x
Debt / EBITDA
5.72x
Net debt / EBITDA
4.45x

Liquidity & coverage

Current ratio
2.27x
Quick ratio
1.70x
Cash ratio
0.85x
Interest coverage
5.79x
EBITDA / interest
8.33x
Working capital
$759.1M

Cash & dividend

FCF / debt
0.14x
Cash flow / debt
0.16x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.